Peer-influenced content. Sources you trust. No registration required. This is HCN.
Pharmacy Practice News
Sufentanil sublingual tablet 30 mcg (Dsuvia, AcelRx), an effective novel tablet formulation of the synthetic opioid sufentanil, has been given FDA approval for the management of severe acute pain in adult patients in licensed medically supervised healthcare settings. The medication is administered sublingually in a single-dose, prefilled applicator.
Clinical Pharmacology September 8th 2022
JAMA Network
In this double-blind randomized clinical trial with 93 participants, the percentage of heavy drinking days during 32 weeks of follow-up was significantly lower in the psilocybin group than in the diphenhydramine group and was accompanied by a decrease in daily alcohol consumption.
Psychiatry September 6th 2022
The results of this study provide evidence that genetically predicted global cortical thickness (GCT) wasassociated with alcoholic drinks consumed per week and binge drinking frequency afteraccounting for neuropsychiatric phenotypes, substance use, trauma, andneurodegeneration.
Psychiatry August 16th 2022
MDLinx
Researchers studied the effects of four repeated low doses of LSD, administered under lab conditions every three to four days, using approximately 1/8th the dose typically used to “trip” on LSD.
Psychiatry August 8th 2022
Drug Policy Alliance
Here’s everything you could possibly want to know about “magic” mushrooms, including their short- and long-term effects on people, risks, history, and much more.
Clinical Pharmacology August 5th 2022
In 2021, melatonin was the most frequently reported substance involved in pediatric substance ingestions, resulting in 4,000 hospitalizations, 287 ICU admissions, and 2 deaths in children under the age of 2. Melatonin supplements can have 500% more melatonin than indicated on the label and about 30% of OTC products tested had serotonin as well.
Emergency Medicine July 19th 2022